ALKBH5 and neoplasm: However, ALKBH5 knockout (KO) showed more dramatic effects in immune-complete (C57) mice than in immune-deficient (NSC) mice in suppressing tumor growth with a lower ratio of tumor volume (KO/NC) (Fig. 1F).